Expression of functional markers in acute nonlymphoblastic leukemia

Acta Haematologica

Volumn 104, Issue 4, 2000, Pages 174-180

  Han, Kyungja ^a   Kahng, Jimin ^a   Kim, Myungshin ^a   Lim, Jihyang ^a   Kim, Yonggoo ^a   Cho, Bin ^a   Kim, Hack Ki ^a   Min, Woo Sung ^a   Kim, Chun Choo ^a   Lee, Kyo Young ^a   Kim, Byung Kee ^a   Kang, Chang Suk ^a,b  

^a The Catholic University of Korea College of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Adhesion molecules; Cell cycle; CSF receptor; Functional marker; Multidrug resistance

Indexed keywords

CELL ADHESION MOLECULE; COLONY STIMULATING FACTOR; COLONY STIMULATING FACTOR RECEPTOR; DNA TOPOISOMERASE (ATP HYDROLYSING); GELATINASE A; GLYCOPROTEIN P; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; HERMES ANTIGEN; KI 67 ANTIGEN; LUNG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN; VASCULOTROPIN;

ACUTE NONLYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CELL CYCLE; CELL INFILTRATION; CHILD; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEPATOMEGALY; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLENOMEGALY;

ADOLESCENT; AGED; ANTIGENS, SURFACE; BONE MARROW CELLS; CELL ADHESION MOLECULES; CELL CYCLE; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT; LEUKEMIA, NONLYMPHOCYTIC, ACUTE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; RECEPTORS, COLONY-STIMULATING FACTOR; RECURRENCE; REMISSION INDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 17744395099     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000046511     Document Type: Article

References (37)

1. Morphologic, immunologic, and cytogenetic classification of acute myeloid leukemia and myelodysplastic syndrome in childhood: A report from the Childrens Cancer Group
2. Acute myelogenous leukemia: Morphologic classification and response to therapy
3. Morphological classification, response to therapy and survival in 263 adult patients with acute nonlymphoblastic leukemia
4. Features affecting outcome during remission induction of acute myeloid leukaemia in 619 adult patients
5. Surface marker expression in adult acute myeloid leukaemia: Correlations with initial characteristics, morphology and response to therapy
6. Diagnostic and prognostic utility of cell surface markers in acute non-lymphocytic leukemia
7. Adult acute leukemia
8. Cell surface antigens in leukemias and lymphomas
9. Syndromes of acute nonlymphocytic leukemia
10. The prognostic significance of the CD34 antigen in acute myeloid leukaemia
11. Cell surface P-glycoprotein is associated with multidrug-resistance in mammalian cells
12. How cancer cells evade chemotherapy: Sixteenth Richard and Hinda Rosenthal Foundation Award Lecture
13. P-Glycoprotein expression in patients with acute leukemia - Clinical relevance
14. Expression of P-glycoprotein (MDR1) gene in patients with leukemia
15. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line
16. Multidrug resistance in acute leukemia: A comparison of different diagnostic methods
17. Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia
18. Drug resistance in multiple myeloma
19. Non-P-glycoprotein drug export mechanisms of multidrug resistance
20. Treatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC 833 (Valspodar)
21. In situ detection of matrix metalloproteinase-2 (MMP-2) and the metalloproteinase inhibitor TIMP2 transcripts in human primary hepatocellular carcinoma and in liver metastasis
22. Differential expression of adhesion molecules in acute leukemia
23. Overexpression of matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in liver from patients with gastrointestinal adenocarcinoma and no detectable metastasis
24. Recombinant human granulocyte-macrophage colony-stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia
25. Frequent gene expression of granulocyte colony-stimulating factor (G-CSF) receptor in CD7+ surface CD3- acute lymphoblastic leukemia
26. Effects of topoisomerase I inhibition on the expression of topoisomerase IIα measured with fluorescence image cytometry
27. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections
28. Cell cycle kinetics in childhood acute leukemia studied with in vitro bromodeoxyuridine labeling, Ki67-reactivity, and flow cytometry
29. P-Glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells
30. P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo acute non-lymphocytic leukemias: Biological and clinical implications
31. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: A Southwest Oncology Group Study
32. Expression of resistance genes in acute leukemia
33. Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia
34. Expression level of MDR1, and MRP in patients with malignant blood disease and its clinical significance
35. Matrix metalloproteinase-2 concentrations in squamous cell carcinoma of the head and neck and its clinical significance
36. Analysis of the granulocyte colony-stimulating factor receptor gene structure using PCR-SSCP in myeloid leukemia and myelodysplastic syndrome
37. Leukemic cells with 11q23 translocations express granulocyte colony-stimulating factor (G-CSF) receptor and their proliferation is stimulated with G-CSF